Finance

Lists
330350:KOSDAQ
Withus Pharmaceutical Co Ltd
â‚©7,350.00
+4.55%
(+320.00) 1D
Sep 4, 3:30:20 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 330350...
Open
â‚©7,030
High
â‚©7,940
Low
â‚©6,820
Mkt. cap
97.02B
Avg. vol.
606.91K
Volume
1.35M
P/E ratio
13.30
52-wk high
â‚©11,950
52-wk low
â‚©5,910
EPS
â‚©552
Shares outstanding
13.20M
No. of employees
223
Open
â‚©7,030
High
â‚©7,940
Low
â‚©6,820
Mkt. cap
97.02B
Avg. vol.
606.91K
Volume
1.35M
P/E ratio
13.30
52-wk high
â‚©11,950
52-wk low
â‚©5,910
EPS
â‚©552
Shares outstanding
13.20M
No. of employees
223
About Withus Pharmaceutical Co Ltd
CEO-
Employees223
Founded2004
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
27.25B
27.18B
28.22B
29.07B
Cost of goods sold
9.53B
9.88B
10.00B
10.42B
Cost of revenue
9.53B
9.88B
10.00B
10.42B
Research and development expenses
-
452.18M
565.05M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16.35B
15.00B
16.79B
17.57B
Operating expense
16.35B
15.92B
17.98B
17.57B
Total operating expenses
25.88B
25.80B
27.97B
28.00B
Operating income
1.37B
1.38B
244.17M
1.08B
Other non operating income
1.26B
-108.94M
113.80M
1.40B
EBT including unusual items
2.63B
-1.57B
711.51M
2.47B
EBT excluding unusual items
2.63B
1.26B
370.21M
2.47B
Income tax expense
483.36M
-1.45B
-3.26B
505.02M
Effective tax rate
18.39%
92.33%
-458.19%
20.42%
Other operating expenses
-
40.81M
53.43M
-
Net income
2.14B
-120.28M
3.97B
1.97B
Net profit margin
7.87%
-0.44%
14.08%
6.77%
Earnings per share
-
-
-
-
Interest and investment income
-
151.87M
155.00M
-
Interest expense
-
-165.04M
-138.27M
-
Net interest expenses
-
-13.17M
16.73M
-
Depreciation and amortization charges
-
92.72M
149.77M
-
EBITDA
2.41B
2.43B
1.32B
2.16B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps